Products & Services · Total Revenue

Stand-ready manufacturing revenue — Total Revenue

Moderna Stand-ready manufacturing revenue — Total Revenue increased by 166.7% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 166.7%, from $12.00M to $32.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful monetization of manufacturing infrastructure and expanded strategic partnerships, while a decrease may signal the expiration of capacity-reservation contracts or a shift in partnership strategy.

Detailed definition

This metric represents revenue generated from contractual arrangements where the company maintains manufacturing capacit...

Peer comparison

Similar to contract manufacturing organization (CMO) service fees or capacity reservation payments found in other large-scale biopharmaceutical or industrial manufacturing firms.

Metric ID: mrna_segment_stand_ready_manufacturing_revenue_total_revenue

Historical Data

10 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$12.00M$32.00M
QoQ Change+166.7%
YoY Change+166.7%
Range$0.00$32.00M
Avg YoY Growth+166.7%
Median YoY Growth+166.7%

Frequently Asked Questions

What is Moderna's stand-ready manufacturing revenue — total revenue?
Moderna (MRNA) reported stand-ready manufacturing revenue — total revenue of $32.00M in Q1 2026.
How has Moderna's stand-ready manufacturing revenue — total revenue changed year-over-year?
Moderna's stand-ready manufacturing revenue — total revenue increased by 166.7% year-over-year, from $12.00M to $32.00M.
What does stand-ready manufacturing revenue — total revenue mean?
Revenue earned by maintaining manufacturing capacity and operational readiness for external partners.